| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/09/2008 | EP1874754A1 Pure duloxetine hydrochloride |
| 01/09/2008 | EP1874750A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
| 01/09/2008 | EP1874747A1 Histamine h3-recept0r ligands and their therapeutic application |
| 01/09/2008 | EP1874735A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/09/2008 | EP1874730A1 Substituted butyrophenone derivatives |
| 01/09/2008 | EP1874353A1 Glutamate modulating agents in the treatment of mental disorders |
| 01/09/2008 | EP1874350A2 Method for treating dementia or alzheimer's disease with a cd20 antibody |
| 01/09/2008 | EP1874336A2 Method of improving learning and memory in mammals |
| 01/09/2008 | EP1874311A2 A method for preventing, delaying or reverting abnormal amyloid deposition |
| 01/09/2008 | EP1874310A2 Opioid receptor agonist compounds and their use in treatment of pain |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1874300A2 Method for treating apathy syndrome |
| 01/09/2008 | EP1874288A1 Acetyl l-carnitine for preventing painful peripheral diabetic neuropathy |
| 01/09/2008 | EP1874282A2 Methods and compositions for treatment of cns disorders |
| 01/09/2008 | EP1761541B1 Pyrrazolo-pyrimidine derivatives |
| 01/09/2008 | EP1685142B1 Phosphinic acid derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/09/2008 | EP1638934B1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/09/2008 | EP1620409B1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 01/09/2008 | EP1556378B1 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1527048B1 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 01/09/2008 | EP1501828B1 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders |
| 01/09/2008 | EP1409449B1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1311270B1 Non-sedating barbiturate compounds as neuroprotective agents |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |
| 01/09/2008 | EP0814789B2 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/09/2008 | CN101103112A Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 |
| 01/09/2008 | CN101103034A Amino-imidazolones for the inhibition of beta-secretase |
| 01/09/2008 | CN101103020A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 01/09/2008 | CN101103019A 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 01/09/2008 | CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators |
| 01/09/2008 | CN101103008A Macrocyclic compounds useful as bace inhibitors |
| 01/09/2008 | CN101102994A Polymorphs of memantine hydrochloride |
| 01/09/2008 | CN101102781A Chlorite in the treatment of neurodegenerative disease |
| 01/09/2008 | CN101102779A Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation |
| 01/09/2008 | CN101102771A Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury |
| 01/09/2008 | CN101102767A Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury |
| 01/09/2008 | CN101102759A Glycine reuptake inhibitors for treating drug and alcohol dependence |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101100455A 5,9-methylenecyclooctyl(b)pyridin-2(1H)-one derivative with ease pain action and its preparation and application |
| 01/09/2008 | CN101100422A Process for the preparation of (2R)-2-propyloctanoic acid |
| 01/09/2008 | CN101099838A Traditional Chinese medicine for treating female menopausal syndrome |
| 01/09/2008 | CN101099835A Traditional Chinese medicine preparation for treating Parkinson's disease |
| 01/09/2008 | CN101099834A Chinese medicinal herb compound for treating neuralgia |
| 01/09/2008 | CN101099831A Traditional Chinese medicinal composition for treating children epilepsy and its preparation method |
| 01/09/2008 | CN101099828A Soft capsule for reducing blood pressure and improving sleeping |
| 01/09/2008 | CN101099807A Traditional Chinese medicine for treating old lumbar spine fracture sequela protrusion of the intervertebral disc ssciatica |
| 01/09/2008 | CN101099778A Medicated wine for treating waist and leg neuralgia |
| 01/09/2008 | CN101099763A Traditional Chinese medicine for treating headache |
| 01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/09/2008 | CN101099740A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/09/2008 | CN101099736A Methods and compositions for treatment of central nervous system disorders |
| 01/09/2008 | CN100360628C Adhesive |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/09/2008 | CN100360538C Thienopyrimidine compound and use of the same |
| 01/09/2008 | CN100360522C Novel compounds having selective inhibiting effect at GSK3 |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360178C Antisenescence medicine |
| 01/09/2008 | CN100360152C Medicinal composition for treating insomnia and its preparing process |
| 01/09/2008 | CN100360147C Medicinal composition, and its pharmaceutical use |
| 01/09/2008 | CN100360141C Calf-blood deprotein extract gel |
| 01/09/2008 | CN100360140C Calf-blood deprotein capsules and preparation thereof |
| 01/09/2008 | CN100360135C Double-layer delayed-releasing tablet of seudo-ginseng general saponin and production thereof |
| 01/09/2008 | CN100360133C Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/09/2008 | CN100360128C Huperzine-A oral cavity disintegration tablet and its preparation method |
| 01/09/2008 | CN100360123C Methods and pharmaceutical compostions employing desmethylselegiline |
| 01/08/2008 | US7317115 Mandelates salts of substituted tetracyclic tetrahydrofuran derivatives |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
| 01/08/2008 | US7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | US7316997 GH secretagogues and uses thereof |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2410237C Adenosine a2a receptor antagonists |
| 01/08/2008 | CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them |
| 01/08/2008 | CA2296031C Novel spiroazabicyclic heterocyclic compounds |
| 01/08/2008 | CA2235375C Production of analgesic synergy by co-administration of sub-analgesic doses of a .mu. opioid agonist and a .kappa.-2 opioid agonist |
| 01/08/2008 | CA2232310C Stable compositions containing n-propargyl-1-aminoindan |
| 01/08/2008 | CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 01/08/2008 | CA2175603C Estrogen compositions and methods for neuroprotection |
| 01/03/2008 | WO2008003093A2 Pharmaceutical compositions and related methods of treatment |
| 01/03/2008 | WO2008002974A1 Pyrrole derivatives and their methods of use |